ROCHESTER, N.Y.--(BUSINESS WIRE)--Bausch & Lomb (NYSE:BOL) today announced that the United States Food and Drug Administration (FDA) has completed an inspection of the company’s Greenville, S.C. solutions manufacturing plant and distribution center. The results of that inspection confirmed Bausch & Lomb’s conviction that both facilities are in acceptable compliance.
